Extract from the Register of European Patents

EP About this file: EP2175873

EP2175873 - PEPTIDE INHIBITORS OF NMDA RECEPTOR FOR USE IN TREATING ANXIETY DISORDERS [Right-click to bookmark this link]
Former [2010/16]TREATMENT FOR ANXIETY
[2014/15]
StatusNo opposition filed within time limit
Status updated on  16.09.2016
Database last updated on 19.03.2026
Most recent event   Tooltip17.08.2018Lapse of the patent in a contracting state
New state(s): BG
published on 19.09.2018  [2018/38]
Applicant(s)For all designated states
NoNO Inc.
88 Strath Avenue
Toronto ON M8X 1R5 / CA
[2012/20]
Former [2010/16]For all designated states
Nono, Inc.
88 Strath Avenue
Toronto, ON M8X 1R5 / CA
For all designated states
Arbor Vita Corporation
772 Lucerne Drive
Sunnyvale, CA 94085 / US
Inventor(s)01 / TASKER, Andrew
RR 9, Station Main
Charlottetown, Prince Edward Island C1E 1Z3 / CA
02 / DOUCETTE, Tracy
46 Beaver Run Road
Stanhope, Prince Edward Island C0A 1P0 / CA
03 / TYMIANSKI, Michael
175 Dawlish Avenue
Toronto
Ontario M4N 1H6 / CA
04 / MENDOZA, Kenneth
432 Euclid Avenue
Oakland, California 94610 / US
05 / BELMARES, Michael, P.
4628 Thimbleberry Lane
San Jose, California 95129 / US
06 / GARMAN, David
148 Lawrie Drive
Vaughan Ontario L4J 8N1 / US
07 / LU, Peter, S.
593 Center Drive
Palo Alto, California 94301 / US
 [2015/46]
Former [2010/26]01 / TASKER, Andrew
RR 9, Station Main Charlottetown
Prince Edward Island C1E 1Z3 / CA
02 / DOUCETTE, Tracy
46 Beaver Run Road Stanhope
Prince Edward Island C0A 1P0 / CA
03 / TYMIANSKI, Michael
175 Dawlish Avenue Toronto
Ontario M4N 1H6 / CA
04 / MENDOZA, Kenneth
432 Euclid Avenue
Oakland, California 94610 / US
05 / BELMARES, Michael, P.
4628 Thimbleberry Lane
San Jose, California 95129 / US
06 / GARMAN, David
148 Lawrie Drive
Vaughan Ontario L4J 8N1 / US
07 / LU, Peter, S.
593 Center Drive
Palo Alto, California 94301 / US
Former [2010/16]01 / TASKER, Andrew
RR 9, Station Main Charlottetown
Prince Edward Island C1E 1Z3 / CA
02 / DOUCETTE, Tracy
46 Beaver Run Road Stanhope
Prince Edward Island C0A 1P0 / CA
03 / TYMIANSKI, Michael
175 Dawlish Avenue Toronto
Ontario M4N 1H6 / CA
04 / MENDOZA, Kenneth
432 Euclid Avenue
Oakland, California 94610 / US
05 / BELMARES, Michael, P.
4628 Thimbleberry Lane
San Jose, California 95129 / US
06 / GARMAN, David
5084 McCoy Avenue
San Jose, California 95130 / US
07 / LU, Peter, S.
593 Center Drive
Palo Alto, California 94301 / US
Representative(s)Green, Mark Charles, et al
Murgitroyd & Company London
Euston House
24 Eversholt Street
London NW1 1AD / GB
[N/P]
Former [2015/46]Green, Mark Charles, et al
Urquhart-Dykes & Lord LLP The Podium
1 Eversholt Street
London NW1 2DN / GB
Former [2010/16]Green, Mark Charles, et al
Urquhart-Dykes & Lord LLP 30 Welbeck Street
London W1G 8ER / GB
Application number, filing date08772390.402.07.2008
[2010/16]
WO2008US69085
Priority number, dateUS20070947892P03.07.2007         Original published format: US 947892 P
[2010/16]
Filing languageEN
Procedural languageEN
PublicationType: A2 Application without search report
No.:WO2009006548
Date:08.01.2009
Language:EN
[2009/02]
Type: A2 Application without search report 
No.:EP2175873
Date:21.04.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 08.01.2009 takes the place of the publication of the European patent application.
[2010/16]
Type: B1 Patent specification 
No.:EP2175873
Date:11.11.2015
Language:EN
[2015/46]
Search report(s)International search report - published on:US19.03.2009
(Supplementary) European search report - dispatched on:EP01.09.2011
ClassificationIPC:A61K38/07, A61K38/17
[2014/15]
CPC:
A61K38/1787 (EP,KR,US); A61K38/04 (KR); A61K38/07 (EP,US);
A61P25/18 (EP); A61P25/22 (EP)
Former IPC [2011/40]A61P25/18, A61K38/17
Former IPC [2010/16]A61K38/04, C12P21/04
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   NO,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2015/46]
Former [2010/16]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  MT,  NL,  NO,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesALNot yet paid
BANot yet paid
MKNot yet paid
RSNot yet paid
TitleGerman:PEPTID-INHIBITOREN ZUR BEHANDLUNG VON ANGSTSYNDROM[2015/28]
English:PEPTIDE INHIBITORS OF NMDA RECEPTOR FOR USE IN TREATING ANXIETY DISORDERS[2015/28]
French:PEPTIDES INHIBITEURS DE RÉCEPTEURS NMDA POUR LE TRAITEMENT DES TROUBLES ANXIEUX[2015/36]
Former [2010/16]BEHANDLUNG VON ANGSTZUSTÄNDEN
Former [2010/16]TREATMENT FOR ANXIETY
Former [2010/16]TRAITEMENT CONTRE L'ANXIÉTÉ
Entry into regional phase01.02.2010National basic fee paid 
01.02.2010Search fee paid 
01.02.2010Designation fee(s) paid 
01.02.2010Examination fee paid 
Examination procedure01.02.2010Examination requested  [2010/16]
23.03.2010Amendment by applicant (claims and/or description)
11.03.2013Despatch of a communication from the examining division (Time limit: M04)
12.07.2013Reply to a communication from the examining division
11.06.2014Communication of intention to grant the patent
25.09.2014Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
24.10.2014Communication of intention to grant the patent
04.11.2014Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
15.01.2015Communication of intention to grant the patent
15.05.2015Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO
04.08.2015Communication of intention to grant the patent
01.10.2015Fee for grant paid
01.10.2015Fee for publishing/printing paid
01.10.2015Receipt of the translation of the claim(s)
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  11.03.2013
Opposition(s)12.08.2016No opposition filed within time limit [2016/42]
Fees paidRenewal fee
22.06.2010Renewal fee patent year 03
12.07.2011Renewal fee patent year 04
13.07.2012Renewal fee patent year 05
10.07.2013Renewal fee patent year 06
14.07.2014Renewal fee patent year 07
10.07.2015Renewal fee patent year 08
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipHU02.07.2008
AT11.11.2015
BE11.11.2015
BG11.11.2015
CY11.11.2015
CZ11.11.2015
EE11.11.2015
FI11.11.2015
HR11.11.2015
LT11.11.2015
LV11.11.2015
MC11.11.2015
NL11.11.2015
PL11.11.2015
RO11.11.2015
SI11.11.2015
SK11.11.2015
TR11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
LU02.07.2016
MT31.07.2016
[2018/38]
Former [2018/33]HU02.07.2008
AT11.11.2015
BE11.11.2015
CY11.11.2015
CZ11.11.2015
EE11.11.2015
FI11.11.2015
HR11.11.2015
LT11.11.2015
LV11.11.2015
MC11.11.2015
NL11.11.2015
PL11.11.2015
RO11.11.2015
SI11.11.2015
SK11.11.2015
TR11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
LU02.07.2016
MT31.07.2016
Former [2018/29]HU02.07.2008
AT11.11.2015
BE11.11.2015
CY11.11.2015
CZ11.11.2015
EE11.11.2015
FI11.11.2015
HR11.11.2015
LT11.11.2015
LV11.11.2015
MC11.11.2015
NL11.11.2015
PL11.11.2015
RO11.11.2015
SI11.11.2015
SK11.11.2015
TR11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
LU02.07.2016
Former [2018/28]HU02.07.2008
AT11.11.2015
BE11.11.2015
CY11.11.2015
CZ11.11.2015
EE11.11.2015
FI11.11.2015
HR11.11.2015
LT11.11.2015
LV11.11.2015
MC11.11.2015
NL11.11.2015
PL11.11.2015
RO11.11.2015
SI11.11.2015
SK11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
LU02.07.2016
Former [2017/44]AT11.11.2015
BE11.11.2015
CZ11.11.2015
EE11.11.2015
FI11.11.2015
HR11.11.2015
LT11.11.2015
LV11.11.2015
MC11.11.2015
NL11.11.2015
PL11.11.2015
RO11.11.2015
SI11.11.2015
SK11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
LU02.07.2016
Former [2017/22]AT11.11.2015
BE11.11.2015
CZ11.11.2015
EE11.11.2015
FI11.11.2015
HR11.11.2015
LT11.11.2015
LV11.11.2015
MC11.11.2015
NL11.11.2015
PL11.11.2015
RO11.11.2015
SI11.11.2015
SK11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
Former [2017/03]AT11.11.2015
BE11.11.2015
CZ11.11.2015
EE11.11.2015
FI11.11.2015
HR11.11.2015
LT11.11.2015
LV11.11.2015
NL11.11.2015
PL11.11.2015
RO11.11.2015
SI11.11.2015
SK11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
Former [2016/49]AT11.11.2015
CZ11.11.2015
EE11.11.2015
FI11.11.2015
HR11.11.2015
LT11.11.2015
LV11.11.2015
NL11.11.2015
PL11.11.2015
RO11.11.2015
SI11.11.2015
SK11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
Former [2016/36]AT11.11.2015
CZ11.11.2015
EE11.11.2015
FI11.11.2015
HR11.11.2015
LT11.11.2015
LV11.11.2015
NL11.11.2015
PL11.11.2015
RO11.11.2015
SK11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
Former [2016/34]AT11.11.2015
CZ11.11.2015
FI11.11.2015
HR11.11.2015
LT11.11.2015
LV11.11.2015
NL11.11.2015
PL11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
Former [2016/25]AT11.11.2015
FI11.11.2015
HR11.11.2015
LT11.11.2015
LV11.11.2015
NL11.11.2015
PL11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
Former [2016/24]AT11.11.2015
FI11.11.2015
HR11.11.2015
LT11.11.2015
NL11.11.2015
PL11.11.2015
NO11.02.2016
GR12.02.2016
IS11.03.2016
PT11.03.2016
Former [2016/23]HR11.11.2015
LT11.11.2015
NL11.11.2015
NO11.02.2016
IS11.03.2016
Former [2016/22]LT11.11.2015
NL11.11.2015
NO11.02.2016
IS11.03.2016
Former [2016/21]LT11.11.2015
NO11.02.2016
Former [2016/20]LT11.11.2015
Documents cited:Search[I] WO2004045535  (ARBOR VITA CORP et al.) [I] 1-13 * page 3, line 5 - page 4, line 20 page 4, lines 21-26;; example 3 *
 [A]   YAKA ET AL: "Effect of varied gestational stress on acquisition of spatial memory, hippocampal LTP and synaptic proteins in juvenile male rats", BEHAVIOURAL BRAIN RESEARCH, ELSEVIER, AMSTERDAM, NL, vol. 179, no. 1, 23 March 2007 (2007-03-23), pages 126 - 132, XP005935162, ISSN: 0166-4328 [A] 1-13
International search[Y]   AARTS ET AL.: "Treatment of ischemic brain damage by pertubing NMDA receptor PSD-95 protein", SCIENCE, vol. 298, 2002, pages 846 - 850, XP002476284

DOI:   http://dx.doi.org/10.1126/science.1072873
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.